Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A randomized, multicenter, phase IIIb open-label study to evaluate the efficacy of sequential therapy of PeginterferOn alfa-2a (PegasysⓇ) following ENTecavir compared with Peginterferon alfa-2a monotherapy in patients with HBeAg positive chronic hepatitis B: Interim analysis of POTENT study
- Authors
- 손주현
- Issue Date
- 12-Nov-2012
- Place
- 미국 보스톤
- Conference Name
- the Liver Meeting” (63th AASLD meeting)
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.